Cti Biopharma Corp

GEODE CAPITAL MANAGEMENT, LLC

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

2,029,780

Value ($000)

8,525

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	8,525	0.0%	2,029,780	3/31/2023
2022 Q4	2/13/2023	11,501	0.0%	1,913,754	12/31/2022
2022 Q3	11/14/2022	10,353	0.0%	1,778,969	9/30/2022
2022 Q2	8/12/2022	9,483	0.0%	1,588,547	6/30/2022
2022 Q1	5/13/2022	3,631	0.0%	777,616	3/31/2022
2021 Q4	2/11/2022	1,692	0.0%	682,626	12/31/2021
2021 Q3	11/12/2021	1,943	0.0%	658,826	9/30/2021
2021 Q2	8/13/2021	1,472	0.0%	589,150	6/30/2021
2021 Q1	5/12/2021	1,404	0.0%	482,648	3/31/2021
2020 Q4	2/12/2021	1,388	0.0%	431,081	12/31/2020
2020 Q3	11/13/2020	895	0.0%	416,437	9/30/2020
2020 Q2	8/13/2020	491	0.0%	423,585	6/30/2020
2020 Q1	5/14/2020	382	0.0%	416,013	3/31/2020
2019 Q4	2/13/2020	634	0.0%	401,743	12/31/2019